GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $50,000 | 0.0% | 1,150 | 0.0% | 0.02% | +14.3% |
| Q1 2022 | $50,000 | -2.0% | 1,150 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | +15.9% | 1,150 | 0.0% | 0.01% | +7.7% |
| Q3 2021 | $44,000 | -42.1% | 1,150 | -39.9% | 0.01% | -43.5% |
| Q2 2021 | $76,000 | +90.0% | 1,915 | +71.7% | 0.02% | +76.9% |
| Q1 2021 | $40,000 | -2.4% | 1,115 | 0.0% | 0.01% | -7.1% |
| Q4 2020 | $41,000 | -2.4% | 1,115 | 0.0% | 0.01% | -17.6% |
| Q3 2020 | $42,000 | -6.7% | 1,115 | 0.0% | 0.02% | +21.4% |
| Q2 2020 | $45,000 | +275.0% | 1,115 | +254.0% | 0.01% | +180.0% |
| Q1 2020 | $12,000 | -67.6% | 315 | -59.8% | 0.01% | -66.7% |
| Q4 2019 | $37,000 | +164.3% | 783 | +148.6% | 0.02% | +87.5% |
| Q3 2019 | $14,000 | -50.0% | 315 | -55.0% | 0.01% | -52.9% |
| Q2 2019 | $28,000 | -24.3% | 700 | -22.2% | 0.02% | -32.0% |
| Q1 2019 | $37,000 | – | 900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |